Furthermore, in vitro experiments revealed that SPRYD4 over-expression inhibited CCA cell proliferation and migration, while the proliferative and migratory capacity of CCA cells was significantly enhanced after SPRYD4 deletion. The gene discussed is SPRYD4; the disease is cholangiocarcinoma.